Table of Contents

Clinical Studies

• You have access

  Postoperative Treatment of Resectable Pancreatic Cancer With Positive Peritoneal Lavage Cytology: A Multicentre Retrospective Study

  AKIKO TODAKA, SATOSHI NARA, FUYUHIKO MOTOI, SOICHIRO MORINAGA, REISHI TOSHIYAMA, RYOTA HIGUCHI, MASARU KONISHI, HIROFUMI SHIRAKAWA, HIDETAKA TSUMURA, HIROYUKI OKUYAMA, HIROAKI NAGANO, KAZUHIKO SHIOJI, KEISHI SUGIMACHI, AKINORI ASAGI, NOBUMASA MIZUNO and JUNJI FURUSE

  Anticancer Research February 2022, 42 (2) 893-902; DOI: https://doi.org/10.21873/anticanres.15547
• You have access

  Feasibility and Safety of Laparoscopic Gallbladder Resection for Gallbladder Tumours

  HAJIME IMAMURA, TOMOHIKO ADACHI, TAKAYUKI TANAKA, HAJIME MATSUSHIMA, TAKANOBU HARA, AKIHIKO SOYAMA, MASAAKI HIDAKA and SUSUMU EGUCHI

  Anticancer Research February 2022, 42 (2) 903-910; DOI: https://doi.org/10.21873/anticanres.15548
• You have access

  Peritumoral Hyperintensity at Hepatobiliary Phase Gadoxetic Acid–enhanced MRI in Hepatic Neuroendocrine Tumors

  NOBUHIRO FUJITA, ATSUHIKO HANDA and JINHA M. PARK

  Anticancer Research February 2022, 42 (2) 911-917; DOI: https://doi.org/10.21873/anticanres.15549
• You have access

  Outcomes of Intramedullary Nail Fixation for Metastatic Disease: Impending and Pathologic Fractures

  AARON R. OWEN, MASON E. UVODICH, VIVEK SOMASUNDARAM, BRANDON J. YUAN, PETER S. ROSE and MATTHEW T. HOUDEK

  Anticancer Research February 2022, 42 (2) 919-922; DOI: https://doi.org/10.21873/anticanres.15550
• You have access

  Implementation of Locoregional Adjuvant Radiotherapy for Breast Cancer in a Rural Healthcare Region: Toxicity Outcomes in the Initial Cohort

  CARSTEN NIEDER, JOAKIM RESSHEIM, ELLINOR C. HAUKLAND and BÅRD MANNSÅKER

  Anticancer Research February 2022, 42 (2) 923-928; DOI: https://doi.org/10.21873/anticanres.15551
• You have access

  Sacral Chordoma: A Population-based Analysis of Epidemiology and Survival Outcomes

  MATTEO SCAMPA, ENRICO TESSITORE, DENNIS E. DOMINGUEZ, DIDIER HANNOUCHE, NICOLAS C. BUCHS, DANIEL F. KALBERMATTEN and CARLO M. ORANGES

  Anticancer Research February 2022, 42 (2) 929-937; DOI: https://doi.org/10.21873/anticanres.15552
• You have access

  Utility of Follow-up With Absolute Lymphocyte Count in Patients Undergoing Eribulin Treatment for Early Detection of Progressive Advanced or Metastatic Breast Cancer

  WATARU GOTO, SHINICHIRO KASHIWAGI, KOJI TAKADA, YUKA ASANO, TAMAMI MORISAKI, MASATSUNE SHIBUTANI, HIROAKI TANAKA, KOSEI HIRAKAWA and MASAICHI OHIRA

  Anticancer Research February 2022, 42 (2) 939-946; DOI: https://doi.org/10.21873/anticanres.15553
• You have access

  Computed Tomography-assessed Skeletal Muscle Index and Skeletal Muscle Radiation Attenuation in Patients With Ovarian Cancer Treated With Primary Surgery Followed by Platinum-based Chemotherapy: A Single-center Italian Study

  ANGIOLO GADDUCCI, ENRICO SIMONETTI, FRANCESCO MEZZAPESA, STEFANIA COSIO, MARIO MICCOLI, JESSICA FREY, RACHELE TINTORI, ALESSANDRA BULLERI and EMANUELE NERI

  Anticancer Research February 2022, 42 (2) 947-954; DOI: https://doi.org/10.21873/anticanres.15554
• You have access

  Hope as a Lifeline: Imatinib Discontinuation in Patients With Oligometastatic Gastrointestinal Stromal Tumours

  LENA FAUSKE, PERNILLE H. WÆRSTAD, IVAR HOMPLAND and ØYVIND S. BRULAND

  Anticancer Research February 2022, 42 (2) 955-963; DOI: https://doi.org/10.21873/anticanres.15555
• You have access

  Circulating Markers of Neutrophil Extracellular Traps (NETs) in Patients With Ovarian Tumors

  ARTURAS DOBILAS, CHARLOTTE THALIN, HAKAN WALLEN and CHRISTER BORGFELDT

  Anticancer Research February 2022, 42 (2) 965-971; DOI: https://doi.org/10.21873/anticanres.15556
• You have access

  Comparative Efficacy of Combination Therapy of Ipilimumab Plus Nivolumab for Non-clear Cell Renal Cell Carcinoma

  YUKARI BANDO, JUNYA FURUKAWA, YASUYOSHI OKAMURA, TAKUTO HARA, TOMOAKI TERAKAWA, YUZO NAKANO and MASATO FUJISAWA

  Anticancer Research February 2022, 42 (2) 973-979; DOI: https://doi.org/10.21873/anticanres.15557
• You have access

  Treatment Efficacy of PD-1 Inhibitor Therapy in Patients With Recurrent and/or Metastatic Salivary Gland Carcinoma

  KAZUKI HASHIMOTO, RYUJI YASUMATSU, RYOSUKE KUGA, TAKAHIRO HONGO, HIDETAKA YAMAMOTO, MIOKO MATSUO, TAKAHIRO WAKASAKI, RINA JIROMARU, TOMOMI MANAKO, SATOSHI TOH, MUNEYUKI MASUDA, MORIYASU YAMAUCHI, YUICHIRO KURATOMI, HIDEOKI URYU, TORAHIKO NAKASHIMA, AKIHIRO TAMAE, RISA TANAKA, MASAHIKO TAURA, TORANOSHIN TAKEUCHI, TAKAMASA YOSHIDA and TAKASHI NAKAGAWA

  Anticancer Research February 2022, 42 (2) 981-989; DOI: https://doi.org/10.21873/anticanres.15558
• You have access

  Intensified Total Neoadjuvant Therapy Versus Intensified Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: A Propensity Score Matching Analysis

  FRANCESCA DE FELICE, DANIELA MUSIO, FRANCO IAFRATE, SALVATORE CAPONNETTO, VINCENZO PICONE, GIANCARLO D’AMBROSIO, FABIO MASSIMO MAGLIOCCA, FRANCESCA TOZZI, GIORGIO DE TOMA, VINCENZO TOMBOLINI and ENRICO CORTESI

  Anticancer Research February 2022, 42 (2) 991-1000; DOI: https://doi.org/10.21873/anticanres.15559
• You have access

  Second-look Surgery Detects Low Volume Recurrent Disease Following Cytoreductive Surgery for Peritoneal Carcinomatosis

  AMER MATAR, KHALED ALTOUKHI, ANDREW TSE, JENNY SOHN, NAYEF ALZAHRANI and DAVID L. MORRIS

  Anticancer Research February 2022, 42 (2) 1001-1006; DOI: https://doi.org/10.21873/anticanres.15560
• You have access

  Efficacy of Ring Drape and Unused Sterile Instruments for Incisional SSI After Hepatectomy

  TOSHIHIKO YUSA, YO-ICHI YAMASHITA, HIDETOSHI NITTA, YOSUKE NAKAO, RUMI ITOYAMA, YUKI KITANO, TAKAYOSHI KAIDA, TATSUNORI MIYATA, KOSUKE MIMA, KATSUNORI IMAI, HIROMITSU HAYASHI and HIDEO BABA

  Anticancer Research February 2022, 42 (2) 1007-1012; DOI: https://doi.org/10.21873/anticanres.15561
• You have access

  Pre-pectoral Immediate Breast Reconstruction Following Conservative Mastectomy Using Acellular Dermal Matrix and Semi-smooth Implants

  UMAR WAZIR, NEILL PATANI, JENNIFER HEENEY, KINAN MOKBEL and KEFAH MOKBEL

  Anticancer Research February 2022, 42 (2) 1013-1018; DOI: https://doi.org/10.21873/anticanres.15562
• You have access

  Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Doxorubicin for 90 Minutes Versus 60 Minutes After Cytoreductive Surgery (CRS). Does the 30-Minute Difference Matter? A Comparative Study in a High Volume Centre

  MIKLOS ACS, LASZLO HALMY, SABINA ISGANDAROVA, SEBASTIAN BLAJ, MICHAEL GERKEN, BERNHARD HORMANN and POMPILIU PISO

  Anticancer Research February 2022, 42 (2) 1019-1029; DOI: https://doi.org/10.21873/anticanres.15563
• You have access

  Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 “MELPOMENI” study)

  ATHANASIOS ALEXOPOULOS, CHARISIOS KARANIKIOTIS, ALEXANDROS ARDAVANIS, IOANNIS BOUKOVINAS, PARISIOS MAKRANTONAKIS, CHRISTOS PAPADIMITRIOU, ATHANASIOS ATHANASIADIS, ANASTASIOS BOUTIS, STYLIANOS GIASSAS, STYLIANOS KAKOLYRIS, GEORGIOS KOUMAKIS, KONSTANTINOS PAPAZISIS, ADAMANTIA PSYRRI, NIKOLAOS ZIRAS, SOFIA BAKA, NIKOLAOS KENTEPOZIDIS and VASILIKI MICHALAKI

  Anticancer Research February 2022, 42 (2) 1031-1041; DOI: https://doi.org/10.21873/anticanres.15564
• You have access

  Risk Factors for Hepatic Toxicity of High-dose Methotrexate in Patients With Osteosarcoma

  KENTARO ABE, AYAKO MAEDA-MINAMI, TAKU ISHIZU, SHINTARO IWATA, EISUKE KOBAYASHI, TATSUNORI SHIMOI, YOHEI KAWANO, HIRONOBU HASHIMOTO, MASAKAZU YAMAGUCHI, TETSUYA FURUKAWA, SATORU MIYAZAKI and YASUNARI MANO

  Anticancer Research February 2022, 42 (2) 1043-1050; DOI: https://doi.org/10.21873/anticanres.15565
• You have access

  Prognostic and Clinicopathological Significance of Lymph Node Metastasis in the Esophagogastric Junction Adenocarcinoma

  NAOKI URAKAWA, SHINGO KANAJI, SATOSHI SUZUKI, RYUICHIRO SAWADA, HITOSHI HARADA, HIRONOBU GOTO, HIROSHI HASEGAWA, KIMIHIRO YAMASHITA, TAKERU MATSUDA, TARO OSHIKIRI and YOSHIHIRO KAKEJI

  Anticancer Research February 2022, 42 (2) 1051-1057; DOI: https://doi.org/10.21873/anticanres.15566
• You have access

  Spontaneous Chromosomal Aberrations in Lymphocytes and Development of Tumor in Hospital Workers

  GYÖNGYI FARKAS, ZSUZSA S. KOCSIS, GÁBOR SZÉKELY, ISTVÁN KENESSEY, CSABA POLGÁR and ZSOLT JURÁNYI

  Anticancer Research February 2022, 42 (2) 1059-1064; DOI: https://doi.org/10.21873/anticanres.15567
• You have access

  Ra-223 and Ethinylestradiol Combination Therapy in Castration-resistant Prostate Cancer

  TAKAFUMI SHIMADA, KOUJI IZUMI, HIROSHI KANO, SUGURU KADOMOTO, TOMOYUKI MAKINO, RENATO NAITO, HIROAKI IWAMOTO, HIROSHI YAEGASHI, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI

  Anticancer Research February 2022, 42 (2) 1065-1071; DOI: https://doi.org/10.21873/anticanres.15568
• You have access

  Differences in the Therapeutic Effect of Chemotherapy Regimens for Concurrent Chemoradiotherapy of Locally Advanced Non-small Cell Lung Cancer

  MINORU HORIUCHI, TETSUYA OGURI, YUSUKE KAGAWA, KAZUKI SONE, SATOSHI FUKUDA, TAKEHIRO UEMURA, OSAMU TAKAKUWA, KEN MAENO, KENNSUKE FUKUMITSU, YOSHIHIRO KANEMITSU, TOMOKO TAJIRI, HIROTSUGU OHKUBO, MASAYA TAKEMURA, YUTAKA ITO and AKIO NIIMI

  Anticancer Research February 2022, 42 (2) 1073-1079; DOI: https://doi.org/10.21873/anticanres.15569
• You have access

  Pretreatment Neutrophil Count and Platelet-lymphocyte Ratio as Predictors of Metastasis in Patients With Osteosarcoma

  YOSHIHIRO ARAKI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, KENSAKU ABE, YUTA TANIGUCHI, HIROTAKA YONEZAWA, SEI MORINAGA, YOHEI ASANO and HIROYUKI TSUCHIYA

  Anticancer Research February 2022, 42 (2) 1081-1089; DOI: https://doi.org/10.21873/anticanres.15570
• You have access

  Investigation of Hypersensitivity Reactions in Carboplatin Desensitization Therapy

  NAOKI SHIBATA, KAZUYOSHI KAWAKAMI, SHIMIZU HISANORI, KAZUO KOBAYASHI, MAYU YUNOKAWA, HIROYUKI KANAO, IORI TAKI, REMI MURASE, DAISUKE KAMEI and MASAKAZU YAMAGUCHI

  Anticancer Research February 2022, 42 (2) 1091-1097; DOI: https://doi.org/10.21873/anticanres.15571
• You have access

  Subsequent-abemaciclib Treatment After Disease Progression on Palbociclib in Patients With ER-positive HER2-negative Metastatic Breast Cancer

  HIROHITO SEKI, TAKASHI SAKURAI, AKIHISA SAKURADA, TETSUHIKO KINOSHITA and KEN SHIMIZU

  Anticancer Research February 2022, 42 (2) 1099-1106; DOI: https://doi.org/10.21873/anticanres.15572
• You have access

  Prognostic Significance of 3-Month Prostate-specific Antigen Level Following Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer

  YUJIRO NAGATA, TAKUO MATSUKAWA, IKKO TOMISAKI and NAOHIRO FUJIMOTO

  Anticancer Research February 2022, 42 (2) 1107-1114; DOI: https://doi.org/10.21873/anticanres.15573
• You have access

  Increased Transumbilical Incision Complication Rates With Laparoscopic Colorectal Resection: A Single-center Propensity Score-matched Cohort Study

  KODAI TOMIOKA, TAKESHI AOKI, MAKOTO WATANABE, YUTA ENAMI, AKIRA FUJIMORI, TOMOTAKE KOIZUMI, SATORU GOTO, KIMIYASU YAMAZAKI, KOJI OTSUKA and MASAHIKO MURAKAMI

  Anticancer Research February 2022, 42 (2) 1115-1121; DOI: https://doi.org/10.21873/anticanres.15574
• You have access

  Risk and Protective Factors for Postoperative Complications in Elderly Patients With Colorectal Cancer

  TAKUYA SHIRAISHI, HIROOMI OGAWA, NAOYA OZAWA, KUNIHIKO SUGA, CHIKA KOMINE, YUTA SHIBASAKI, KATSUYA OSONE, TAKUHISA OKADA, YASUAKI ENOKIDA, MAKOTO SOHDA, KEN SHIRABE and HIROSHI SAEKI

  Anticancer Research February 2022, 42 (2) 1123-1130; DOI: https://doi.org/10.21873/anticanres.15575
• You have access

  Platelet-to-Lymphocyte Ratio Predicts the Efficacy of Pembrolizumab in Patients With Urothelial Carcinoma

  RYO KURASHINA, KIYOHIRO ANDO, MASAHARU INOUE, KEITA IZUMI, RIKO MARUYAMA, KOUKI MITANI, HISANORI TAKENOBU, MASAYUKI HARUTA, TOSHIHIKO IIZUKA, TAKEHIKO KAMIJO and YUKIO KAGEYAMA

  Anticancer Research February 2022, 42 (2) 1131-1136; DOI: https://doi.org/10.21873/anticanres.15576
• You have access

  Consideration of the Optimal Surgical Procedure Based on the Risk of Recurrence in Clinical Stage 0 or IA Lung Adenocarcinoma

  TOMOYOSHI TAKENAKA, TETSUZO TAGAWA, MIKIHIRO KOHNO, NAOKI HARATAKE, FUMIHIKO KINOSHITA, YUKI ONO, SHO WAKASU, YUKA OKU and MASAKI MORI

  Anticancer Research February 2022, 42 (2) 1137-1142; DOI: https://doi.org/10.21873/anticanres.15577
• You have access

  High vs. Standard Radiotherapy Dose in Locally Advanced Rectal Adenocarcinoma Patients Treated With Neoadjuvant Long Course Chemoradiotherapy: A Population-based Study

  JI-AN LIANG, YU-CHENG KUO, K.S. CLIFFORD CHAO, WILLIAM TZU-LIANG CHEN, TAO-WEI KE, SZU-HSIEN CHOU, CHIA-CHIN LI and CHUN-RU CHIEN

  Anticancer Research February 2022, 42 (2) 1143-1150; DOI: https://doi.org/10.21873/anticanres.15578
• You have access

  Awake Surgery for Local Recurrence of Brain Metastasis in the Precentral Gyrus After Fractionated Stereotactic Radiotherapy: A Technical Case Report

  RYOSUKE MATSUDA, FUMIYA SATO, MASASHI KOTSUGI, TAKAYUKI MORIMOTO, FUMIHIKO NISHIMURA, ICHIRO NAKAGAWA and HIROYUKI NAKASE

  Anticancer Research February 2022, 42 (2) 1151-1155; DOI: https://doi.org/10.21873/anticanres.15579
• You have access

  Bilateral Lung Transplant for Treatment of Idiopathic Pulmonary Fibrosis With Undetected Lung Adenocarcinoma: A Case Report

  UZAIR M. JOGIAT, QUINCY S. CHU, JAYAN NAGENDRAN, BRYCE LAING, ALIM HIRJI and BENJAMIN A. ADAM

  Anticancer Research February 2022, 42 (2) 1157-1160; DOI: https://doi.org/10.21873/anticanres.15580
• You have access

  Efficacy and Safety of Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Living Donor Liver Transplantation: A Report of Two Cases

  AKIHIKO ICHIDA, NOBUHISA AKAMATSU, RIHITO NAGATA, YUICHIRO MIHARA, YOSHIKUNI KAWAGUCHI, SUNG KWAN BAE, TAKEAKI ISHIZAWA, JUNICHI KANEKO, JUNICHI ARITA and KIYOSHI HASEGAWA

  Anticancer Research February 2022, 42 (2) 1161-1167; DOI: https://doi.org/10.21873/anticanres.15581
• You have access

  A Rare Case of Brain Metastasis of Thymic Carcinoma

  TAKAAKI MITSUI, RYOSUKE MATSUDA, KAZUO GODA, HIROE ITAMI, ICHIRO NAKAGAWA and HIROYUKI NAKASE

  Anticancer Research February 2022, 42 (2) 1169-1174; DOI: https://doi.org/10.21873/anticanres.15582
• You have access

  Stratified Mucin-producing Intraepithelial Lesions of the Cervix: Clinical Diversity of Cases and Literature Review

  CHARLOTTE DELRUE, LIEVE VANWALLEGHEM, PASCALE DE PAEPE and PHILIPPE VAN TRAPPEN

  Anticancer Research February 2022, 42 (2) 1175-1180; DOI: https://doi.org/10.21873/anticanres.15583
• You have access

  Republication: A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells – An Analysis for Patients With Incurable Pancreatic Cancer

  YOSHIYUKI YAMAGUCHI, YOUSUKE KATATA, MAKOTO OKAWAKI, AKIRA SAWAKI and MASAHIRO YAMAMURA

  Anticancer Research February 2022, 42 (2) 1181-1187; DOI: https://doi.org/10.21873/anticanres.15584